Cancer Blood Tests Jumpstart Diagnoses
New research shows blood tests used to hunt for cancer DNA may help detect cancers faster and guide the use of targeted therapies
Read MorePosted by Andy Lundin | Nov 29, 2023 | Cancer, Molecular Diagnostics |
New research shows blood tests used to hunt for cancer DNA may help detect cancers faster and guide the use of targeted therapies
Read MorePosted by Chris Wolski | Nov 22, 2023 | Prostate |
Men with biomarker HSD3B1 may exhibit resistance to combined radiation and hormone therapy for prostate cancer.
Read MorePosted by Chris Wolski | Nov 15, 2023 | Cancer |
Timely cancer detection paves the way for interventions that are less toxic, less disruptive, and less costly than treatment in later stages.
Read MorePosted by Andy Lundin | Nov 9, 2023 | Miscellaneous, Sample Storage & Management |
Quest Mobile is a service designed to make it easier and more convenient for patients to have a specimen collected for lab testing nationwide.
Read MorePosted by Andy Lundin | Nov 7, 2023 | Company News, Molecular Diagnostics |
Veracyte and Illumina will develop high-performing molecular tests as decentralized IVD tests on Illumina’s NextSeq 550Dx NGS instrument.
Read More